Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

China flag China · Delayed Price · Currency is CNY
9.93
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST
27.96%
Market Cap 4.96B
Revenue (ttm) 924.53M
Net Income (ttm) 81.67M
Shares Out 499.58M
EPS (ttm) 0.16
PE Ratio 62.06
Forward PE n/a
Dividend 0.15 (1.52%)
Ex-Dividend Date Jul 25, 2025
Volume 7,284,194
Average Volume 19,240,549
Open 10.23
Previous Close 9.93
Day's Range 9.88 - 10.23
52-Week Range 7.75 - 15.21
Beta 1.92
RSI 31.64
Earnings Date Apr 28, 2026

About SHE:002728

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company’s products are used in respiratory system, cardiovascular and cerebrovascular, respiratory, cardiovascular, and digestive systems. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. The company was founded in 2002 an... [Read more]

Sector Healthcare
Founded 2002
Employees 1,434
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002728
Full Company Profile

Financial Performance

In 2025, SHE:002728's revenue was 924.53 million, an increase of 34.42% compared to the previous year's 687.79 million. Earnings were 81.67 million, an increase of 298.50%.

Financial Statements

News

There is no news available yet.